On the cover: Inhibition of PDGF-B signaling blocks mural cell recruitment and results in mural cell stripping of corneal neo-vessels, allowing vessel regression in an ocular injury model. Corneas from injured mice, treated from day 10 to 20 with the anti-PDGF receptor-{beta} antibody APB5, demonstrate decreased mural cell coverage compared to PBS controls. Endothelial cells were labeled by staining for lectin (green) and mural cells by staining for smooth muscle actin (red). (See page 2036).